RT Journal Article SR Electronic T1 Earliest infections predict the age distribution of seasonal influenza A cases JF medRxiv FD Cold Spring Harbor Laboratory Press SP 19001875 DO 10.1101/19001875 A1 Philip Arevalo A1 Huong Q. McLean A1 Edward A. Belongia A1 Sarah Cobey YR 2020 UL http://medrxiv.org/content/early/2020/03/29/19001875.abstract AB Seasonal variation in the age distribution of influenza A cases suggests that factors other than age shape susceptibility to medically attended infection. We ask whether these differences can be partly explained by protection conferred by childhood influenza infection, which has lasting impacts on immune responses to influenza and protection against new influenza A subtypes (phenomena known as original antigenic sin and immune imprinting). Fitting a statistical model to data from studies of influenza vaccine effectiveness (VE), we find that primary infection appears to reduce the risk of medically attended infection with that subtype throughout life. This effect is stronger for H1N1 compared to H3N2. Additionally, we find evidence that VE varies with both age and birth year, suggesting that VE is sensitive to early exposures. Our findings may improve estimates of age-specific risk and VE in similarly vaccinated populations and thus improve forecasting and vaccination strategies to combat seasonal influenza.Competing Interest StatementThe authors report grants from National Institutes of Health during the conduct of the study. HQM receives research support from Seqirus unrelated to this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Funding StatementFunding for this project was provided by the National Institutes of Health (NIH), Department of Health and Human Services, under grant DP2AI117921 (to SC), CEIRS Contract No. HHSN272201400005C (to SC), and NRSA Fellowship F32AI145177-01 (to PA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesData for this study are available at www.github.com/cobeylab/FluAImprinting https://github.com/cobeylab/FluAImprinting